Literature DB >> 16269310

Expression of glial cell line-derived neurotrophic factor family members and their receptors in pancreatic cancers.

Yoshinori Ito1, Yuji Okada, Mikinori Sato, Hirozumi Sawai, Hitoshi Funahashi, Takayuki Murase, Tetsushi Hayakawa, Tadao Manabe.   

Abstract

BACKGROUND: The glial cell line-derived neurotrophic factor (GDNF) is a member of neurotrophic polypeptide family, which promotes survival and rescue of various neural cells in the central and peripheral nerve systems. We previously reported that GDNF promotes tumor cell invasion in pancreatic cancer cell lines. The purpose of this study was to investigate GDNF family expression and the status of related receptors in actual cancer tissues, and assess correlations with clinicopathologic behavior.
METHODS: Immunohistochemical assessment of GDNF, neurturin, persephin, artemin, GDNF family receptor alpha-1 and alpha-2, and RET was performed for 51 cases of surgically resected pancreatic cancer.
RESULTS: In all intrapancreatic nerves, GDNF and artermin were expressed strongly. In pancreatic cancer tissues. The expression of RET was stronger than that seen in normal ductal cells and was significantly related to the survival rate after resection (P = .026) and lymphatic invasion (P = .014). Intrapancreatic neural invasion was significantly related to the expression of GDNF (P = .047).
CONCLUSIONS: We conclude that the expression of RET in pancreatic cancer tissues may be a useful prognostic marker and GDNF may play an important role in neural invasion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16269310     DOI: 10.1016/j.surg.2005.07.007

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  31 in total

Review 1.  Perineural invasion and associated pain in pancreatic cancer.

Authors:  Aditi A Bapat; Galen Hostetter; Daniel D Von Hoff; Haiyong Han
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

Review 2.  Perineural growth in head and neck squamous cell carcinoma: a review.

Authors:  Joseph Roh; Thomas Muelleman; Ossama Tawfik; Sufi M Thomas
Journal:  Oral Oncol       Date:  2014-10-25       Impact factor: 5.337

Review 3.  New biomarkers and targets in pancreatic cancer and their application to treatment.

Authors:  Eithne Costello; William Greenhalf; John P Neoptolemos
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-06-26       Impact factor: 46.802

Review 4.  RET revisited: expanding the oncogenic portfolio.

Authors:  Lois M Mulligan
Journal:  Nat Rev Cancer       Date:  2014-03       Impact factor: 60.716

5.  RET isoforms contribute differentially to invasive processes in pancreatic ductal adenocarcinoma.

Authors:  Eric Y Lian; Brandy D Hyndman; Serisha Moodley; Sarah M Maritan; Lois M Mulligan
Journal:  Oncogene       Date:  2020-09-03       Impact factor: 9.867

6.  Systemic Depletion of Nerve Growth Factor Inhibits Disease Progression in a Genetically Engineered Model of Pancreatic Ductal Adenocarcinoma.

Authors:  Jami L Saloman; Aatur D Singhi; Douglas J Hartman; Daniel P Normolle; Kathryn M Albers; Brian M Davis
Journal:  Pancreas       Date:  2018-08       Impact factor: 3.327

Review 7.  Thyroid C-Cell Biology and Oncogenic Transformation.

Authors:  Gilbert J Cote; Elizabeth G Grubbs; Marie-Claude Hofmann
Journal:  Recent Results Cancer Res       Date:  2015

Review 8.  CXCR2 and RET single nucleotide polymorphisms in pancreatic cancer.

Authors:  Timothy R Donahue; O Joe Hines
Journal:  World J Surg       Date:  2009-04       Impact factor: 3.352

9.  Expression analysis of Barrett's esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue.

Authors:  Edmond Sabo; Patricia A Meitner; Rosemarie Tavares; Christopher L Corless; Gregory Y Lauwers; Steven F Moss; Murray B Resnick
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

10.  Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves.

Authors:  Ziv Gil; Oren Cavel; Kaitlyn Kelly; Peter Brader; Avigail Rein; Sizhi P Gao; Diane L Carlson; Jatin P Shah; Yuman Fong; Richard J Wong
Journal:  J Natl Cancer Inst       Date:  2010-01-12       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.